First Trust Advisors LP Axcella Health Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.98 - $4.31 $134,138 - $194,006	-45,013 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.08 - $5.13 $4,312 - $7,182	-1,400 Reduced 3.02%	45,013 $181,000
Q1 2021 May 14, 2021	BUY	$4.55 - $6.72 $16,948 - $25,032	3,725 Added 8.73%	46,413 $221,000
Q4 2020 Feb 02, 2021	SELL	$4.24 - $5.97 $2,666 - $3,755	-629 Reduced 1.45%	42,688 $222,000
Q3 2020 Nov 05, 2020	BUY	$4.12 - $5.91 $178,466 - $256,003	43,317 New	43,317 $200,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.